72.19.Z - Scientific research and development activities
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 29,8 | |||
Gross profit (loss) | 4 | 6,2 | 7,3 | 16,9 |
EBITDA | 4 | 6,3 | 7,3 | 17,3 |
Short time liabilities | 3,1 | 4,4 | 6,1 | 40,6 |
Other operating costs | -96,2 | |||
Equity capital | 12,5 | 17,3 | 22,8 | 31,9 |
Operating profit (EBIT) | 4 | 6,2 | 7,3 | 17,9 |
Assets | 18,7 | 26,3 | 35 | 33,1 |
Net profit (loss) | 3,1 | 4,8 | 5,5 | 15 |
Cash | 6,3 | 7,6 | 3,6 | -52,2 |
Net income from sale | 74,9 | 107 | 123,3 | 15,2 |
Liabilities and provisions for liabilities | 6,2 | 9 | 12,2 | 35,3 |
Working assets | 18,1 | 25,4 | 33,8 | 33,2 |
Other income costs | -99,5 | |||
Depreciation | 0 | 0 | 0 | -66,2 |
% | % | % | p.p. | |
Profitability of capital | 24,6 | 27,8 | 24,2 | -3,6 |
Equity capital to total assets | 66,7 | 65,7 | 65,1 | -0,6 |
Gross profit margin | 5,4 | 5,8 | 5,9 | 0,1 |
EBITDA Margin | 5,4 | 5,8 | 6 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 15 | 15 | 18 | 3 |
Current financial liquidity indicator | -2,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane